Albuterol Administration for Infants and Young Children with Acute Wheezing
Preferred Delivery Method
- A metered‑dose inhaler (MDI) with a spacer and appropriately sized face mask is the recommended first‑line delivery system for infants and toddlers, offering comparable or superior efficacy to nebulization while being more economical and convenient. 1, 2
MDI Dosing Protocol for Acute Exacerbations
- Initiate treatment with 2 puffs (total 180 µg albuterol) via MDI‑spacer‑mask, repeating the dose every 20 minutes for the first three administrations. 1, 3
- After the initial three doses, administer additional doses every 1–4 hours as needed based on clinical response. 3
Weight‑Based Dosing Alternative (MDI)
- For children whose weight is known, give approximately 50 µg albuterol per kilogram per treatment (≈2 puffs for a child weighing 10–13 kg). This regimen may be repeated up to a cumulative total of 20 puffs in severe cases. 4, 1
Nebulizer Dosing (When MDI‑Spacer Is Not Feasible)
- Deliver 0.15 mg albuterol per kilogram (minimum 2.5 mg) via nebulizer.
- Dilute the medication to a minimum total volume of 3 mL with normal saline to ensure adequate aerosol generation. 5
- Use an oxygen‑driven nebulizer with a flow rate of 6–8 L/min. 6
- Administer the nebulized dose every 20 minutes for three doses, then every 1–4 hours as needed. 6, 7
Safety Monitoring
- Observe for rare β‑adrenergic side effects such as tachycardia and tremor; these events are uncommon with inhaled albuterol. 3
Management of Severe or Life‑Threatening Exacerbations
- Add ipratropium bromide 250 µg to the nebulized regimen (or give 2–3 puffs of ipratropium via MDI every 20 minutes for three doses) to enhance bronchodilation. 4
- In exceptionally severe cases, the 20‑minute dosing interval may be continued beyond three doses until clinical improvement is achieved. 6
Practical Considerations
- Ensure a properly fitting face mask to maximize drug delivery efficiency in this age group. 5
Evidence‑Based Recommendations for Albuterol Nebulization in Toddlers
Nebulizer Dosing When MDI‑Spacer Is Not Feasible
In children aged 12–36 months who cannot use a metered‑dose inhaler with spacer, administer albuterol nebulized at 0.15 mg/kg (minimum 2.5 mg) diluted to a total volume of ≥3 mL with normal saline. This dose provides effective bronchodilation in acute wheezing episodes. 8
The nebulizer should be driven by oxygen at 6–8 L/min whenever possible, especially in severe asthma, to optimize aerosol delivery and avoid hypoxia. 8
Adding Ipratropium for Severe or Life‑Threatening Bronchospasm
For severe exacerbations, combine ipratropium bromide 250 µg with each albuterol nebulized treatment (or 2–3 puffs via MDI) administered every 20 minutes for three consecutive doses; this adjunct enhances bronchodilation. 8
After the initial three combination doses, continue ipratropium every 6 hours if further bronchodilation is needed. 8
Safety Monitoring During Inhaled Therapy
- Observe toddlers for clinical signs of deterioration, including fatigue, use of accessory muscles, agitation, reduced consciousness, oxygen saturation persistently < 90 %, or a silent chest; prompt recognition guides escalation of care. 8
Critical Pitfalls to Avoid in Nebulizer Use
- Never use compressed air or room air as the driving gas in hypoxic children; always employ oxygen at 6–8 L/min unless there is a specific concern for CO₂ retention, to prevent worsening hypoxia. 8
Escalation of Care When Inhaled Therapy Fails
- If maximal inhaled therapy (albuterol ± ipratropium) does not achieve clinical improvement, initiate an aminophylline infusion (5 mg/kg loading dose over 20 minutes, then 1 mg/kg/hour) and consider transfer to an intensive‑care setting. 8
Adjunctive Systemic Corticosteroid Therapy
- For persistent symptoms or moderate‑to‑severe exacerbations, add oral prednisolone 2 mg/kg/day for 3 days (maximum 40 mg/day) to improve outcomes in acute asthma episodes. 8